ArticleCancer research2013

The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

Naoto Miyajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.